Skip to main content
SpringerLink
Log in

Ist die Verschiebung des Applikationszeitpunkts zur Vermeidung einer Aspirin/Metamizol-Interaktion bei chronischer Gabe ausreichend?

Is deferment of the time of administration to avoid an aspirin/metamizole interaction by chronic dosing sufficient?

  • Leserbrief
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Achilles A, Mohring A, Dannenberg L et al (2017) Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE. Int J Cardiol 236:76–81

    Article  PubMed  Google Scholar 

  2. Dannenberg L, Erschoff V, Bonner F et al (2016) Dipyrone comedication in aspirin treated stroke patients impairs outcome. Vascul Pharmacol 87:66–69

    Article  CAS  PubMed  Google Scholar 

  3. Dingermann T (2017) Metamizol: Something to think about. Z Rheumatol 76(5):377. doi:10.1007/s00393-017-0317-1

    Article  CAS  PubMed  Google Scholar 

  4. Levy M, Zylber-Katz E, Rosenkranz B (1995) Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 28:216–234

    Article  CAS  PubMed  Google Scholar 

  5. Polzin A, Richter S, Schror K et al (2015) Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost 114:87–95

    Article  PubMed  Google Scholar 

  6. Schmitz A, Romann L, Kienbaum P et al (2017) Dipyrone (metamizole) markedly interferes with platelet inhibition by aspirin in patients with acute and chronic pain: a case-control study. Eur J Anaesthesiol 34:288–296

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Anästhesiologie und Intensivmedizin, Medizinische Universität Graz, Auengriggerplatz 29, 8036, Graz, Deutschland

    H. Bornemann-Cimenti,  S. Fleck &  G. Rumpold Seitlinger

Authors
  1. H. Bornemann-Cimenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Fleck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Rumpold Seitlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Bornemann-Cimenti.

Ethics declarations

Interessenkonflikt

H. Bornemann-Cimenti, S. Fleck und G. Rumpold Seitlinger geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bornemann-Cimenti, H., Fleck, S. & Rumpold Seitlinger, G. Ist die Verschiebung des Applikationszeitpunkts zur Vermeidung einer Aspirin/Metamizol-Interaktion bei chronischer Gabe ausreichend?. Z Rheumatol 76, 552–553 (2017). https://doi.org/10.1007/s00393-017-0332-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-017-0332-2

Search

Navigation